Aevi Genomic Medicine, Inc. (GNMX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 43 transactions totaling $9.3M, demonstrating a bullish sentiment with $8.2M in net insider flow. The most recent transaction on Feb 3, 2020 involved a transaction of 2,164,150 shares valued at $0.
No significant insider buying has been recorded for GNMX in the recent period.
No significant insider selling has been recorded for GNMX in the recent period.
Based on recent SEC filings, insider sentiment for GNMX is bullish with an Insider Alignment Score of 94/100 and a net flow of $8.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Aevi Genomic Medicine, Inc. (GNMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading GNMX stock, having executed 43 transactions in the past 90 days. The most active insider is Sol J. Barer (Executive), who has made 11 transactions totaling $3.8M.
Get notified when executives and directors at GNMX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | Arthur Neil Garry | Executive | Disposition | 2,164,150 | $N/A | $0 | |
| Feb 3, 2020 | F. Cola Michael | Executive | Disposition | 2,267,859 | $N/A | $0 | |
| Feb 3, 2020 | Of Philadelphia Foundation Children's Hospital | Executive | Other | 57,280,927 | $N/A | $0 | |
| Feb 3, 2020 | Of Philadelphia Foundation Children's Hospital | Executive | Other | 38,856,891 | $N/A | $0 | |
| Feb 3, 2020 | J. Clemow Alastair | Executive | Disposition | 57,536 | $N/A | $0 | |
| Feb 3, 2020 | A. Bauer Eugene | Executive | Disposition | 165,715 | $N/A | $0 | |
| Feb 3, 2020 | J. Grano Joseph Jr | Executive | Disposition | 56,780 | $N/A | $0 | |
| Feb 3, 2020 | J. Grano Joseph Jr | Executive | Disposition | 27,000 | $N/A | $0 | |
| Feb 3, 2020 | J. Grano Joseph Jr | Executive | Disposition | 75,683 | $N/A | $0 | |
| Feb 3, 2020 | J. Grano Joseph Jr | Executive | Disposition | 15,384 | $N/A | $0 | |
| Feb 3, 2020 | Gayle Duncan Barbara | Executive | Disposition | 59,524 | $N/A | $0 | |
| Feb 3, 2020 | Mcinaw Michael | Executive | Disposition | 16,107 | $N/A | $0 | |
| Dec 19, 2019 | Medimmune Ltd | Executive | Purchase | 12,946,900 | $N/A | $0 | |
| Dec 5, 2019 | J. Barer Sol | Executive | Other | 2,551,020 | $N/A | $0 | |
| Dec 5, 2019 | J. Barer Sol | Executive | Sale | 4,098,752 | $0.13 | $532.8K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 24 | $8.7M | 94.3% |
Sale(S) | 1 | $532.8K | 5.7% |
Disposition(D) | 10 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insiders at Aevi Genomic Medicine, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 43 transactions totaling $8.7M in purchases versus $532.8K in sales, the net buying activity of $8.2M signals strong executive confidence. Sol J. Barer (Executive) leads the buying activity with $3.8M in transactions across all time.